Merck & Co. logo

Merck & Co. MRK

$ 122.11 2.53%

Annual report 2025
added 02-24-2026

report update icon

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NYSESPB

Shares

2.5 B

Market Cap[1]

$ 306 B

EBITDA (LTM)

$ 2.86 B

P/E (LTM)

15.42

P/S (LTM)

4.34

EPS (LTM)

7.34

Merck & Co., Inc. is a global pharmaceutical company that specializes in the development, manufacturing, and distribution of innovative medicines, vaccines, and animal health products. Founded in 1891, Merck has grown to become one of the largest pharmaceutical companies in the world, with operations in over 140 countries.

The company's mission is to improve the health and well-being of people and animals around the world. Merck is committed to discovering new treatments and cures for some of the most challenging diseases, including cancer, Alzheimer's disease, and HIV/AIDS. The company has a strong pipeline of products in development, with a focus on immunotherapy and oncology.

Merck is also a leader in the development and distribution of vaccines. The company has played a key role in the fight against infectious diseases such as measles, mumps, rubella, and HPV. Merck's vaccines have saved countless lives around the world and continue to be an important tool in preventing disease outbreaks.

In addition to its pharmaceutical and vaccine business, Merck also has a thriving animal health division. The company develops and manufactures products for livestock, pets, and wildlife. Merck's animal health products are used to prevent and treat diseases in animals, improving their health and welfare.

Merck is committed to operating responsibly and sustainably. The company has set ambitious goals to reduce its environmental impact, improve the health and safety of its employees, and support the communities where it operates. Merck has been recognized for its sustainability efforts, including being named to the Dow Jones Sustainability Index for the past 16 years.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
FSD Pharma FSD Pharma
HUGE
- 5743.5 % $ 69.7 M Nasdaq Capital Market canadaCanada
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
- 1.35 % $ 17.8 M Nasdaq Capital Market chinaChina
AgeX Therapeutics AgeX Therapeutics
AGE
- -10.17 % $ 12.2 K NYSE American usaUSA
I-Mab I-Mab
IMAB
- - $ 866 M Nasdaq Global Select Market chinaChina
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
- - $ 2.18 B Nasdaq Global Select Market,SPB usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B Nasdaq Global Select Market usaUSA
Genfit SA Genfit SA
GNFT
- 2.54 % $ 160 B Nasdaq Global Select Market franceFrance
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
Alpine Immune Sciences Alpine Immune Sciences
ALPN
- - $ 2.17 B Nasdaq Global Market usaUSA
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited
ASLN
- -14.27 % $ 1.7 M Nasdaq Global Market singaporeSingapore
AstraZeneca PLC AstraZeneca PLC
AZN
- - $ 96.9 B Nasdaq Global Select Market britainBritain
CureVac N.V. CureVac N.V.
CVAC
- - $ 867 M Nasdaq Global Market germanyGermany
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Athira Pharma Athira Pharma
ATHA
- - $ 269 M Nasdaq Global Select Market usaUSA
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
- 0.74 % $ 768 M Nasdaq Capital Market israelIsrael
Abcam plc Abcam plc
ABCM
- - $ 4.9 B Nasdaq Global Select Market britainBritain
Galera Therapeutics Galera Therapeutics
GRTX
- -32.59 % $ 7.61 M Nasdaq Global Market usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
Affimed N.V. Affimed N.V.
AFMD
- -34.95 % $ 21.5 M Nasdaq Global Select Market,SPB germanyGermany
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
$ 50.62 2.39 % $ 4.55 B Nasdaq Global Market,SPB schweizSchweiz
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - MOEX russiaRussia
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
- - $ 231 M Nasdaq Global Market usaUSA
Celyad Oncology SA Celyad Oncology SA
CYAD
- - $ 12.5 M Nasdaq Global Market belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
- -7.31 % $ 87 M Nasdaq Global Select Market usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
$ 29.98 2.15 % $ 1.99 B Nasdaq Global Select Market usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
- - $ 344 M Nasdaq Global Select Market usaUSA
IMV IMV
IMV
- - $ 13.1 M Nasdaq Global Select Market canadaCanada
Akero Therapeutics Akero Therapeutics
AKRO
- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
Akouos Akouos
AKUS
- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
- - $ 7.46 M Nasdaq Global Market israelIsrael
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
- -4.36 % $ 27 M Nasdaq Capital Market usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
- - $ 384 M Nasdaq Global Select Market britainBritain
Gracell Biotechnologies Gracell Biotechnologies
GRCL
- - $ 3.37 B Nasdaq Global Select Market chinaChina
Anika Therapeutics Anika Therapeutics
ANIK
$ 14.83 -0.77 % $ 213 M Nasdaq Global Select Market,SPB usaUSA
Advaxis Advaxis
ADXS
- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
- - $ 1.01 B Nasdaq Global Market usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
- - $ 26.5 M Nasdaq Global Select Market usaUSA
AIkido Pharma AIkido Pharma
AIKI
- 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
$ 2.86 -1.72 % $ 4.71 M NYSE American israelIsrael
Aptose Biosciences Aptose Biosciences
APTO
- -45.71 % $ 1.2 M Nasdaq Capital Market canadaCanada
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
$ 0.69 3.0 % $ 31.5 M Nasdaq Capital Market israelIsrael
Aptinyx Aptinyx
APTX
- -39.0 % $ 4.57 M Nasdaq Global Select Market usaUSA
Albireo Pharma Albireo Pharma
ALBO
- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
AlloVir AlloVir
ALVR
- 4.14 % $ 49.1 M Nasdaq Global Select Market usaUSA
Allakos Allakos
ALLK
- - $ 28.6 M Nasdaq Global Select Market,SPB usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
$ 24.79 6.72 % $ 3.15 B Nasdaq Global Select Market,SPB usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
- 3.16 % $ 1.9 M Nasdaq Global Select Market usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
- -11.43 % $ 502 K NYSE American usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.